Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|September 30, 2009
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patientsSimone Susser, Christoph Welsch, Yalan Wang, et al.Plos One|November 13, 2014
Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosisBenjamin Maasoumy, Bela Hunyady, Vincenza Calvaruso, et al.Journal of Hepatology|June 17, 2017
Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimerasSimone Susser, Julia Dietz, Bernhard Schlevogt, et al.The Journal of Infectious Diseases|March 13, 2018
Divergent preS Sequences in Virion-Associated Hepatitis B Virus Genomes and Subviral HBV Surface Antigen Particles From HBV e Antigen-Negative PatientsKai-Henrik Peiffer, Lisa Kuhnhenn, Bingfu Jiang, et al.Plos One|November 9, 2013
Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infectionJanett Fischer, Stephan Böhm, Tobias Müller, et al.Journal of Hepatology|December 15, 2016
Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experienceAlessandra Mangia, Simone Susser, Valeria Piazzolla, et al.Journal of Virology|March 29, 2013
Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patientsJulia Dietz, Sven-Eric Schelhorn, Daniel Fitting, et al.Plos One|June 10, 2016
Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple TherapyJulia Dietz, Daniel Rupp, Simone Susser, et al.Journal of Clinical Microbiology|May 3, 2019
Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 ChimerasKai-Henrik Peiffer, Lisa Kuhnhenn, Evelyn Stelzl, et al.Antimicrobial Agents and Chemotherapy|November 9, 2011
Virologic escape during danoprevir (ITMN-191/RG7227) monotherapy is hepatitis C virus subtype dependent and associated with R155K substitutionSharlene R Lim, Xiaoli Qin, Simone Susser, et al.Pageof 4